Anemia and Hypoxia Impact on Chronic Kidney Disease Onset and Progression: Review and Updates
Cureus · 09.10.2023
DOI: 10.7759/cureus.46737 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 09.10.2023. Verfasst von Elmukhtar Habas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Hamad General Hospital, Doha, QAT. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 272 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Chronic kidney disease (CKD) is caused by hypoxia in the renal tissue, leading to inflammation and increased migration of pathogenic cells. Studies showed that leukocytes directly sense hypoxia and respond by initiating gene transcription, encoding the 2-integrin adhesion molecules. Moreover, other mechanisms participate in hypoxia, including anemia. CKD-associated anemia is common, which induces and worsens hypoxia, contributing to CKD progression. Anemia correction can slow CKD progression, but it should be cautiously approached. In this comprehensive review, the underlying pathophysiology mechanisms and the impact of renal tissue hypoxia and anemia in CKD onset and progression will be reviewed and discussed in detail. Searching for the latest updates in PubMed Central, Medline, PubMed database, Google Scholar, and Google search engines were conducted for original studies, including cross-sectional studies, cohort studies, clinical trials, and review articles using different keywords, phrases, and texts such as "CKD progression, anemia in CKD, CKD, anemia effect on CKD progression, anemia effect on CKD progression, and hypoxia and CKD progression". Kidney tissue hypoxia and anemia have an impact on CKD onset and progression. Hypoxia causes nephron cell death, enhancing fibrosis by increasing interstitium protein deposition, inflammatory cell activation, and apoptosis. Severe anemia correction improves life quality and may delay CKD progression. Detection and avoidance of the risk factors of hypoxia prevent recurrent acute kidney injury (AKI) and reduce the CKD rate. A better understanding of kidney hypoxia would prevent AKI and CKD and lead to new therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, Hamad General Hospital, Doha, QAT.
- Internal Medicine, Tripoli University, Tripoli, LBY.
- Hemat-oncology Department, Pediatric Tripoli Hospital, Tripoli University, Tripoli, LBY.
Zitieren
APA
Habas, E., Al Adab, A., Arryes, M., Alfitori, G., Farfar, K., Habas, A. M., Akbar, R. A., Rayani, A., Habas, E., & Elzouki, A. (2023). Anemia and Hypoxia Impact on Chronic Kidney Disease Onset and Progression: Review and Updates. Cureus. https://doi.org/10.7759/cureus.46737
Vancouver
Habas E, Al Adab A, Arryes M, Alfitori G, Farfar K, Habas AM, et al. Anemia and Hypoxia Impact on Chronic Kidney Disease Onset and Progression: Review and Updates. Cureus. 2023. doi:10.7759/cureus.46737
BibTeX
@article{Habas2023,
author = {Habas, Elmukhtar and Al Adab, Aisha and Arryes, Mehdi and Alfitori, Gamal and Farfar, Khalifa and Habas, Ala M and Akbar, Raza A and Rayani, Amnna and Habas, Eshrak and Elzouki, Abdulnaser},
title = {Anemia and Hypoxia Impact on Chronic Kidney Disease Onset and Progression: Review and Updates},
journal = {Cureus},
year = {2023},
doi = {10.7759/cureus.46737}
}
EUVIMED